CA2600935A1 - Utilisation du silicate de cuivre pour controler les infections a l'herpes - Google Patents

Utilisation du silicate de cuivre pour controler les infections a l'herpes Download PDF

Info

Publication number
CA2600935A1
CA2600935A1 CA002600935A CA2600935A CA2600935A1 CA 2600935 A1 CA2600935 A1 CA 2600935A1 CA 002600935 A CA002600935 A CA 002600935A CA 2600935 A CA2600935 A CA 2600935A CA 2600935 A1 CA2600935 A1 CA 2600935A1
Authority
CA
Canada
Prior art keywords
hsv
copper
copper silicate
herpes virus
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002600935A
Other languages
English (en)
Inventor
John Dawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conve Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005901294A external-priority patent/AU2005901294A0/en
Application filed by Individual filed Critical Individual
Publication of CA2600935A1 publication Critical patent/CA2600935A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002600935A 2005-03-16 2006-03-16 Utilisation du silicate de cuivre pour controler les infections a l'herpes Abandoned CA2600935A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2005901294 2005-03-16
AU2005901294A AU2005901294A0 (en) 2005-03-16 Use of Copper Silicate for the Control of HSV Infections
PCT/AU2006/000363 WO2006096937A1 (fr) 2005-03-16 2006-03-16 Utilisation du silicate de cuivre pour controler les infections a l’herpes

Publications (1)

Publication Number Publication Date
CA2600935A1 true CA2600935A1 (fr) 2006-09-21

Family

ID=36991212

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002600935A Abandoned CA2600935A1 (fr) 2005-03-16 2006-03-16 Utilisation du silicate de cuivre pour controler les infections a l'herpes

Country Status (3)

Country Link
EP (1) EP1858531A1 (fr)
CA (1) CA2600935A1 (fr)
WO (1) WO2006096937A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018152614A1 (fr) * 2017-02-21 2018-08-30 Fine Cotton Factory Inc. Articles pour le traitement de commotion et d'autres troubles

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008543885A (ja) 2005-06-20 2008-12-04 ダイナミクリア ピーティーワイ リミテッド 皮膚病変治療用組成物
EP3939599A3 (fr) * 2007-10-15 2022-03-16 HS Pharmaceuticals, LLC Compositions à base de silicate et procédés de traitement
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11007143B2 (en) * 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11318089B2 (en) * 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69224295T2 (de) * 1991-10-17 1998-06-25 Sheen Biotechnology Pty Ltd Pestizid und fungizid
AUPP068497A0 (en) * 1997-12-02 1998-01-08 Sheen Biotechnology Pty Ltd Use of copper for the control of legionella
AUPS179302A0 (en) * 2002-04-17 2002-05-30 Conve Ltd Use of topical compositions for the control of microbial diseases of the nail

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018152614A1 (fr) * 2017-02-21 2018-08-30 Fine Cotton Factory Inc. Articles pour le traitement de commotion et d'autres troubles

Also Published As

Publication number Publication date
EP1858531A1 (fr) 2007-11-28
WO2006096937A1 (fr) 2006-09-21

Similar Documents

Publication Publication Date Title
CA2600935A1 (fr) Utilisation du silicate de cuivre pour controler les infections a l'herpes
AU746756B2 (en) A method of inhibiting formation of infectious herpes virus particles
JPH0676317B2 (ja) 抗ウイルス医薬製剤およびその使用法
US20120093945A1 (en) Method for treating an inflammation or lesion caused by a virus
JP6359217B2 (ja) 新規ヨードフォア組成物および使用方法
EP0109234B1 (fr) Compositions contenant de l'interféron et leur application thérapeutique
RU2302861C2 (ru) Лекарственное средство для лечения вирусных кожных и опухолевых заболеваний
US5696160A (en) Topical composition enhancing healing of viral lesions
KR20000036210A (ko) 장쇄 알코올, 알칸, 지방산 및 아미드로 바이러스를 억제하는 방법
EP0590024B1 (fr) Composition a usage local ameliorant la cicatrisation de lesions dues a l'herpes
JPS6225645B2 (fr)
CA2052246A1 (fr) Traitement au lithium
US6355226B1 (en) Topical treatment of skin disease and eye afflictions
AU2006225096A1 (en) Use of Copper Silicate for the Control of Herpes Infections
US20200022933A1 (en) Surfactants and compositions for treatment of viral skin conditions
CH715156A2 (it) Composizione per il trattamento di una lesione erpetica nascente
IT201800007009A1 (it) Nuovo uso medico di anestetici locali
KR101875997B1 (ko) 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법
JPH07106980B2 (ja) ヘルペスウイルスにより引き起された疾患の治療剤
Sim Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2′-deoxyuridine
US20030153618A1 (en) Treatment and prevention of herpes simplex infections
PL237937B1 (pl) Preparat farmaceutyczny do leczenia zakażenia wirusem herpes simplex

Legal Events

Date Code Title Description
FZDE Dead